- Home
- OKYO vs PRPL Comparison
OKYO vs PRPL Comparison
Compare OKYO & PRPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- OKYO
- PRPL
- Stock Information
- Founded
- OKYO 2007
- PRPL 2010
- Country
- OKYO United Kingdom
- PRPL United States
- Employees
- OKYO N/A
- PRPL N/A
- Industry
- OKYO Biotechnology: Biological Products (No Diagnostic Substances)
- PRPL Home Furnishings
- Sector
- OKYO Health Care
- PRPL Consumer Discretionary
- Exchange
- OKYO Nasdaq
- PRPL Nasdaq
- Market Cap
- OKYO 79.7M
- PRPL 89.8M
- IPO Year
- OKYO 2022
- PRPL N/A
- Fundamental
- Price
- OKYO $1.99
- PRPL $0.79
- Analyst Decision
- OKYO Strong Buy
- PRPL Hold
- Analyst Count
- OKYO 1
- PRPL 1
- Target Price
- OKYO $7.00
- PRPL $1.00
- AVG Volume (30 Days)
- OKYO 118.6K
- PRPL 548.0K
- Earning Date
- OKYO 07-18-2025
- PRPL 11-04-2025
- Dividend Yield
- OKYO N/A
- PRPL N/A
- EPS Growth
- OKYO N/A
- PRPL N/A
- EPS
- OKYO N/A
- PRPL N/A
- Revenue
- OKYO N/A
- PRPL $457,012,000.00
- Revenue This Year
- OKYO N/A
- PRPL N/A
- Revenue Next Year
- OKYO N/A
- PRPL $11.87
- P/E Ratio
- OKYO N/A
- PRPL N/A
- Revenue Growth
- OKYO N/A
- PRPL N/A
- 52 Week Low
- OKYO $0.90
- PRPL $0.56
- 52 Week High
- OKYO $3.35
- PRPL $1.29
- Technical
- Relative Strength Index (RSI)
- OKYO 39.72
- PRPL 52.50
- Support Level
- OKYO $1.90
- PRPL $0.69
- Resistance Level
- OKYO $2.54
- PRPL $0.76
- Average True Range (ATR)
- OKYO 0.25
- PRPL 0.07
- MACD
- OKYO -0.06
- PRPL 0.01
- Stochastic Oscillator
- OKYO 6.83
- PRPL 61.90
About OKYO OKYO Pharma Limited
OKYO Pharma Ltd is a biopharmaceutical company. The company is developing therapeutics to improve the lives of patients with inflammatory eye diseases and chronic pain. It offers solutions for various diseases such as Dry Eye Disease, Non-infectious Anterior Uveitis, Allergenic Conjunctivitis, Chronic Pain, and Ocular Pain.
About PRPL Purple Innovation Inc.
Purple Innovation Inc is a comfort innovation company. The company designs, manufactures and sells a range of comfort technology offerings, including mattresses, a pillow, cushions, sheets, bed platforms and other products. The Company has one reportable segment that operates an omni-channel distribution which allows the Company to offer a seamless shopping experience to its customers across multiple sales channels. It sells its products through its direct-to-consumer e-commerce channels, retail brick-and-mortar wholesale partners, Purple showrooms, and third-party online retailers.